---
title: "Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer: Access and coverage questions"
description: "Access and coverage questions on Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Access and support, and Cost and coverage. Questions: What is the DATROWAY J-code (HCPCS code)? What is the NDC for DATROWAY? What access support is available for DATROWAY (DATROWAY4U)? Is there a DATROWAY patient assistance program? 2 further questions follow. 6 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/access-and-coverage"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer: Access and coverage questions

Manufacturer: Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP  
Prescribing information: [Datroway](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Datroway&inline=true)

## Access and billing

<a id="datroway-jcode"></a>

### What is the DATROWAY J-code (HCPCS code)?

> “DATROWAY J-Code<sup>1,2</sup>
> HCPCS Code	Description	Vial Size	Billing Units	NDC
> J9011	Injection, datopotamab deruxtecan-dlnk, 1mg	100 mg single-dose vial	100 Units	65597-801-01”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=DATROWAY,65597%2D801%2D01)

<a id="datroway-ndc"></a>

### What is the NDC for DATROWAY?

> “DATROWAY (datopotamab deruxtecan-dlnk) for injection is a white to yellowish white lyophilized powder supplied as: 
>
> Carton Contents 
> NDC 
> One 100 mg single-dose vial 
> NDC 65597-801-01”

Source: [DATROWAY: Prescribing information, page 23, captured 2026-11-08](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Datroway&inline=true#page=23)

## Access and support

<a id="datroway-access-services"></a>

### What access support is available for DATROWAY (DATROWAY4U)?

> “Comprehensive Access Support
>
> DATROWAY4U can help with benefit verification, prior authorization assistance, and pharmacy research and coordination. If there is a delay in a patient's coverage decision, DATROWAY4U may be able to provide the first dose at no cost.”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=Comprehensive%20Access%20Support,first%20dose%20at%20no%20cost.)

<a id="datroway-patient-assistance"></a>

### Is there a DATROWAY patient assistance program?

> “Patient Assistance Programs
>
> Designed to help qualifying uninsured, underinsured, or Medicare patients who are having financial difficulty affording their medication. Eligibility rules apply.”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=Patient%20Assistance%20Programs,their%20medication.%20Eligibility%20rules%20apply.)

<a id="datroway-savings-program"></a>

### Is there a DATROWAY copay savings program?

> “DATROWAY Patient Savings Program for commercially insured patients
>
> The goal of the DATROWAY Patient Savings Program is to remove cost as a barrier for eligible commercial patients by assisting with their out-of-pocket costs for DATROWAY.”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=DATROWAY%20Patient%20Savings%20Program%20for,their%20out%2Dof%2Dpocket%20costs%20for%20DATROWAY.)

## Cost and coverage

<a id="datroway-savings-cost"></a>

### How much does DATROWAY cost with the savings program?

> “DATROWAY Patient Savings Program for commercially insured patients”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=DATROWAY%20Patient%20Savings%20Program%20for%20commercially%20insured%20patients)

> “Eligible patients with a valid prescription for DATROWAY may pay as little as $0 per infusion and $0 out-of-pocket costs for DATROWAY, up to $26,000 per calendar year. The annual benefit can be used for the cost of the drug itself and may also cover up to $100 in infusion costs per administration and may also cover multiple eye exams related to the use of DATROWAY up to $250 per exam.* There are no income requirements to participate in the program.”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=Eligible%20patients%20with%20a%20valid,to%20participate%20in%20the%20program.)

> “*Patients who are residents of Massachusetts or Rhode Island are not eligible for infusion administration (or eye exam assistance).”

Source: [DATROWAY: Access & Support, captured 2026-11-08](https://datrowayhcp.com/support-resources/access-support#:~:text=%2APatients%20who%20are%20residents%20of,administration%20%28or%20eye%20exam%20assistance%29.)

## Related pages
- [Medical information: Datroway (datopotamab deruxtecan-dlnk): HR-positive HER2-negative breast cancer](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer)
- [Indication](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/safety)
- [Specific populations](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/datroway--hr-positive-her2-negative-breast-cancer/storage-and-supply)
